Inspire Medical Systems, Inc. INSP

Company Overview

Inspire Medical Systems, Inc. is a U.S.-based medical technology company focused on the development and commercialization of implantable neurostimulation solutions for patients with moderate to severe obstructive sleep apnea (OSA). The company operates within the medical devices and sleep disorder treatment industries, addressing a large patient population that is unable to tolerate or benefit from continuous positive airway pressure (CPAP) therapy.

The company’s primary product is the Inspire therapy system, an implantable hypoglossal nerve stimulation device designed to maintain an open airway during sleep. Inspire targets adult OSA patients who meet specific clinical criteria and are seeking an alternative to traditional treatments. Founded in 2007, the company evolved from early-stage neurostimulation research into a commercial-stage medical device manufacturer following U.S. regulatory approvals and reimbursement expansion, culminating in its initial public offering in 2018.